Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Management of hepatitis B after renal transplantation: an update.

Journal of nephrology - 1 Jan 2000

Fabrizi Fabrizio, Lunghi Giovanna, Poordad Fred F, Martin Paul

Abstract excerpt

Hepatitis B Virus (HBV) infection remains an important cause of liver disease in renal transplant (RT) recipients and the outcome of HBV infected RT recipients is less favorable than that of noninfected RT recipients. The concern about graft loss induced by interferon (IFN) therapy precludes its use; lamivudine, a second-generation analog, has been recently approved for the treatment of hepatitis B and promises...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Drug Resistance, Viral
Share to Hepatitis B, Chronic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis B virus

Share to Interferon-alpha

Share to Kidney Transplantation

Share to Lamivudine

Share to Recurrence

Source

Identifiers

PMID: 12018626

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Management of hepatitis B after renal transplantation: an update.PMID 12018626Read ↗

Management of hepatitis B virus infection in liver transplant recipients: prospects and challenges.Semantic proximity Read ↗

Fulminant hepatic failure resulting from lamivudine-resistant hepatitis B virus in a renal transplant recipient: durable response after orthotopic liver transplantation on adefovir dipivoxil and hepatitis B immune globulin.Semantic proximity Read ↗

Lamivudine therapy of chronic hepatitis B in three groups of patients: non transplanted patients, liver recipients, and kidney recipients.Semantic proximity Read ↗

What are the management issues for hepatitis C in dialysis patients?: renal transplantation from hepatitis C-positive donors.Semantic proximity Read ↗

Management of hepatitis C after transplantation: a long way from success.Semantic proximity Read ↗

Hepatitis C Virus Eradication in Kidney Transplant Recipients: A Single-Center Experience in Portugal.Semantic proximity Read ↗

Pegylated interferon for recurrent hepatitis C in liver transplant recipients with renal failure: a prospective cohort study.Semantic proximity Read ↗

Oral Nucleos(t)ide Analogs Alone After Liver Transplantation in Chronic Hepatitis B With Preexisting rt204 Mutation.Semantic proximity Read ↗

Switching to sirolimus in renal transplant recipients with hepatitis C virus: a safe option.Semantic proximity Read ↗

Hepatitis B escape mutant reactivation in a renal transplant patient.Semantic proximity Read ↗

Management of viral hepatitis B.Semantic proximity Read ↗

Direct-acting antiviral therapy for hepatitis C virus infection in the kidney transplant recipient.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.